Jump to content

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | Madrid
  • Quirónsalud
  • Doubts and queries
  • Web map
  • twitter This link will open in a pop-up window.
  • facebook This link will open in a pop-up window.
  • Youtube This link will open in a pop-up window.
  • Linkedin This link will open in a pop-up window.
  • Instagram This link will open in a pop-up window.
  • Researcher Portal Link to external application.
Language selector
Active language English
  • español
  • English
  • The Institute
    • The Institute
    • Objetives
    • Structure
    • Documents
    • Strategy HRS4R
    • Portal de transparencia
  • Areas and Research Groups
  • Scientific Activity
    • Summary of scientific output
    • Most noteworthy publications
    • Funding
    • Collaborative research
    • Training activities
  • Support Units
    • Research Management Area
    • Core facilities
    • Clinical trials
  • Job
    • Calls and Grants
    • Plan de formación
  • Present
    • News
  • Innovation
    • Who are we?
    • Do you have an idea?
    • Portfolio of services
    • Our technological offers
    • Our successful cases
    • Quality and Innovation Committee
    • Documents
    • Clinical Practice Guidelines
  • Location and contact
  • Colabora con la investigación
  • Portal comunicación interna
  • Home
  •   |   Innovation Unit
  •   |   5. OUR TECHNOLOGICAL OFFERS
  •   |   Pharma
  • Print
  • Tweet
  • Share on Facebook
  • Share on Linkedin
  • Share on WhatsApp

Pharma

  • New treatment for Chronic Kidney Disease based on Aging New treatment for Chronic Kidney Disease based on Aging (329 KB) (1 page)
  • New molecule for the prevention and treatment of Abdominal Aortic Aneurysm New molecule for Aortic Abdominal Aneurysm (AAA) prevention and treatment (319.3 KB) (1 page)
  • New treatment of chronic kidney disease based on the minimization of adverse effects of Albuminuria New treatment for CKD_minimizing albuminuria adverse effects (345 KB) (1 page)
  • Treatment of kidney disease based on the state of histones Renal disease treament based on histone status (311.9 KB) (1 page)
  • New technology to facilitate the recovery of hematpoietic stem cells after bone marrow transplantation HEMATOPOIETIC STEM CELL (166.1 KB) (1 page)
  • New gene therapy for the treatment of PKD PKD GENE EDITING (93.2 KB) (1 page)
  • New gene therapy for the treatment of Epidermolysis Bullosa EPIDERMOLYSIS BULLOSA (124.7 KB) (1 page)
  • Cbase aptamers for the development of pharmacos associated with G protein-coupled receptors GPCRA RECEPTOR AGONIST APTAMERS (136.1 KB) (1 page)
  • In vivo lentiviral gene therapy for the treatment of primary hyperoxaluria type I IN VIVO LENTIVIRAL GENE THERAPY FOR THE TREATMENT OF PRIMARY HYPEROXALURIA TYPE 1 (106.5 KB) (1 page)
  • Lentiviral vectors and their uses LENTIVIRAL VECTORS AND THEIR USES (107.3 KB) (1 page)
  • SEPT6-ABL2 Fusion for use in the diagnosis and/or treatment of cancer SEPT6-ABL2 FUSION (508 KB) (2 pages)
  • Bacteriophages: Pulmonary and infectious deseases. BACTERIOPAHES_PULMONARY AND INFECTIOUS DESEASES (470.1 KB) (2 pages)
  • SOCS1-DERIVED PEPTIDE FOR USE IN CHRONIC COMPLICATIONS OF DIABETES SOCS1-DERIVED PEPTIDE FOR USE IN CHRONIC COMPLICATIONS OF DIABETES (490.5 KB) (1 page)
  • Treatment Meibomian Gland Dysfunction Treatment Meibomian Gland Dysfunction (578.1 KB) (2 pages)
  • banner quironsalud gris
  • AENOR UNE 166002
Hospital Universitario Fundación Jiménez Díaz

Fundación Jiménez Díaz

Avda. Reyes Católicos, 2
28040 Madrid

91 550 48 00
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

Calle Isaac Peral, 42 oficinas. 2ª planta – oficina 1
28015 Madrid

91 550 48 97investigacion@fjd.es
  • Legal notice
  • Protección de datos
  • Cookie policy
  • Accessibility
  • Web Map
  • twitter This link will open in a pop-up window.
  • facebook This link will open in a pop-up window.
  • Youtube This link will open in a pop-up window.
  • Linkedin This link will open in a pop-up window.
  • Instagram This link will open in a pop-up window.

© 2023 Quirónsalud - All rights reserved

Instituto de Investigación Sanitaria acreditado por el Instituto de Salud Carlos III

Logo ISCIII